An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic Leukemia

SIMPLE SUMMARY: B cell acute lymphoblastic leukemia (B-ALL) is a common blood cancer characterized by proliferating and accumulating malignant, immature B cells within the body. Despite recent successes in B-ALL therapy, there is still a need for new therapeutic options. In the present study, we rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Riegg, Fabian, Lutz, Martina S., Schmied, Bastian J., Heitmann, Jonas S., Queudeville, Manon, Lang, Peter, Jung, Gundram, Salih, Helmut R., Märklin, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036612/
https://www.ncbi.nlm.nih.gov/pubmed/33915811
http://dx.doi.org/10.3390/cancers13071632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036612/
https://www.ncbi.nlm.nih.gov/pubmed/33915811
http://dx.doi.org/10.3390/cancers13071632

Ejemplares similares